These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 1428684)

  • 1. [Immunosuppressive therapy in myocarditis and dilated cardiomyopathy?].
    Schultheiss HP
    Internist (Berl); 1992 Oct; 33(10):650-62. PubMed ID: 1428684
    [No Abstract]   [Full Text] [Related]  

  • 2. Successful treatment of severe heart failure caused by idiopathic giant cell myocarditis.
    Desjardins V; Pelletier G; Leung TK; Waters D
    Can J Cardiol; 1992 Oct; 8(8):788-92. PubMed ID: 1422999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myocarditis in children and detection of viruses in myocardial tissue: implications for immunosuppressive therapy.
    Camargo PR; Okay TS; Yamamoto L; Del Negro GM; Lopes AA
    Int J Cardiol; 2011 Apr; 148(2):204-8. PubMed ID: 19945184
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Etiopathogenetic differentiation of inflammatory cardiomyopathy. Immunosuppression and immunomodulation].
    Kühl U; Pauschinger M; Schultheiss HP
    Internist (Berl); 1997 Jun; 38(6):590-601. PubMed ID: 9265004
    [No Abstract]   [Full Text] [Related]  

  • 5. Treatment of chronic myocarditis with corticosteroids.
    Kühl U; Schultheiss HP
    Eur Heart J; 1995 Dec; 16 Suppl O():168-72. PubMed ID: 8682089
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunosuppressive treatment for myocarditis and dilated cardiomyopathy.
    Maisch B; Herzum M; Hufnagel G; Bethge C; Schönian U
    Eur Heart J; 1995 Dec; 16 Suppl O():153-61. PubMed ID: 8682087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Experience with immunosuppressive treatment of autoimmune myocarditis proven by myocardial biopsy].
    Högye M; Móczó I; Forster T; Edes I; Béres I; Szabó E; Tószegi A; Gaál T; Kovács G; Csanády M
    Orv Hetil; 1987 Mar; 128(9):451-7. PubMed ID: 3550587
    [No Abstract]   [Full Text] [Related]  

  • 8. [Immunosuppressive therapy in myocarditis and dilated cardiomyopathy--a critical analysis].
    Schultheiss HP
    Z Kardiol; 1989 Jun; 78(6):349-59. PubMed ID: 2667264
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Current concepts of diagnosis and therapy of myocarditis from the clinico-immunologic viewpoint].
    Hiepe F; Müller S; Förster A; Apostoloff E; Geissler W
    Z Arztl Fortbild (Jena); 1991 Jun; 85(12):547-50. PubMed ID: 1926923
    [No Abstract]   [Full Text] [Related]  

  • 10. Autoimmunity in myocarditis and dilated cardiomyopathy: cardiac autoantibody frequency and clinical correlates in a patient series from Italy.
    Caforio AL; Bauce B; Boffa GM; De Cian F; Angelini A; Melacini P; Razzolini R; Fasoli G; Chioin R; Schiaffino S; Thiene G; Dalla Volta S
    G Ital Cardiol; 1997 Feb; 27(2):106-12. PubMed ID: 9199945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exogenous thioredoxin reduces inflammation in autoimmune myocarditis.
    Lowenstein CJ
    Circulation; 2004 Sep; 110(10):1178-9. PubMed ID: 15353510
    [No Abstract]   [Full Text] [Related]  

  • 12. The Myocarditis Treatment Trial: design, methods and patients enrollment.
    Hahn EA; Hartz VL; Moon TE; O'Connell JB; Herskowitz A; McManus BM; Mason JW
    Eur Heart J; 1995 Dec; 16 Suppl O():162-7. PubMed ID: 8682088
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Dilated cardiomyopathy. An analysis of the viral-immunological theory].
    Aleksandrova LZ; Bakhov NI; Osipov SG; Naumov VG; Titov VN
    Ter Arkh; 1985; 57(4):136-40. PubMed ID: 2990061
    [No Abstract]   [Full Text] [Related]  

  • 14. [Treatment of lymphocytic myocarditis: an unsolved problem].
    Feitosa GS
    Arq Bras Cardiol; 1990 Sep; 55(3):213. PubMed ID: 2095731
    [No Abstract]   [Full Text] [Related]  

  • 15. [Dilated myocarditis and cardiomyopathies. The dysimmune hypothesis].
    Sachs RN
    Arch Mal Coeur Vaiss; 1990 Mar; 83(3):407-11. PubMed ID: 2108636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetically determined myocarditis: clinical presentation and immunological characteristics.
    Caforio AL; Iliceto S
    Curr Opin Cardiol; 2008 May; 23(3):219-26. PubMed ID: 18382209
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Restricted usage of T cell receptor V alpha-V beta genes in infiltrating cells in the hearts of patients with acute myocarditis and dilated cardiomyopathy.
    Seko Y; Ishiyama S; Nishikawa T; Kasajima T; Hiroe M; Kagawa N; Osada K; Suzuki S; Yagita H; Okumura K
    J Clin Invest; 1995 Aug; 96(2):1035-41. PubMed ID: 7635939
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Idiopathic dilated cardiomyopathy: a persistent viral infection or an organ-specific autoimmune disease? The trial of 2 major pathogenetic hypotheses].
    Caforio AL; Bonifacio E; Keeling PJ; Grazzini M; Schiaffino S; Bottazzo GF; McKenna WJ
    G Ital Cardiol; 1992 Jan; 22(1):63-72. PubMed ID: 1624070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Immunosuppressive therapy of myocarditis?].
    Schultheiss HP; Kühl U; Janda I; Schanwell M; Strauer BE
    Herz; 1992 Apr; 17(2):112-21. PubMed ID: 1577363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Autoantibodies against cardiac myosin in patients with myocarditis and dilated cardiomyopathy].
    Lauer B; Padberg K; Schultheiss HP; Strauer BE
    Z Kardiol; 1995 Apr; 84(4):301-10. PubMed ID: 7785303
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.